Tempo Australia Limited operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Tempo Australia Limited with three other
companies in this sector in Australia:
sales of 23.75 million Australian Dollars [US$18.34 million]
of which 100%
was Mesenchymal Precursor Cell),
(58.63 million Australian Dollars [US$45.27 million]
of which 69%
was New Drug Development), and
Xrf Scientific Ltd
(20.67 million Australian Dollars [US$15.96 million]
of which 44%
was Precious Metals).
Sales increased substantially in 2015:
During the year ended December of 2015, sales at
Tempo Australia Limited were A$79.15 million (US$61.12 million).
increase of 393.5%
versus 2014, when the company's sales were A$16.04 million.
This was the fifth consecutive year of sales increases at Tempo Australia Limited
(and since 2010, sales have increased a total of 2,824,802%).